variably fatal when treated appropriately and that the complications associated with relapses, especially in the older population, can be less hazardous than the therapy. The association of antineutrophil cytoplasmic antibodThus, regimens that use effective but less toxic agents ies (ANCA) with the small vessel vasculitides has proved are being actively sought. The risk factors for relapses helpful in the diagnosis and management of Wegener's in the ANCA-associated vasculitides and for the develgranulomatosis, microscopic polyangiitis, and Churgopment of generalized disease in Wegener's granulomaStrauss syndrome, but the lack of technical guidelines tosis are incompletely understood at the present time. for antibody testing had meant that it was often difficult ANCA with specificities other than PR3 and MPO are to compare results from different laboratories. The "Infrequently demonstrated in patients with inflammatory bowel disease, autoimmune liver disease, rheumatoid
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• IIF is performed on all sera, since about 10% of ANCA-positive sera are detected only by IIF • Sera containing ANCA, any other cytoplasmic fluorescence, or an ANA that results in homogeneous or peripheral nuclear
DIAGNOSIS OF SYSTEMIC SMALL
fluorescence should be tested promptly in ELISAs for both
VESSEL VASCULITIDES
PR3-and MPO-ANCA • Sera from patients that were previously ANCA-positive by IIF The ANCA-associated small vessel vasculitides inalone may be tested subsequently only by IIF clude Wegener's granulomatosis, microscopic polyan-
• Sera that were positive for either PR3-or MPO-ANCA may giitis, renal-limited microscopic polyangiitis, Churgbe tested subsequently only in the relevant ELISA (although ANCA sometimes change antigen specificity)
Strauss syndrome, and some drug-induced vasculitides [7] [8] [9] [10] [11] [12] . The term "polyangiitis" is preferred to "polyarte-
Optimal recommendations
• IIF titration should be performed for sera positive only by IIF, ritis" because vessels of various sizes are affected and or if other cytoplasmic fluorescence, or an ANA is present arteries are often not involved. In patients with primary
• ELISAs should be performed on all sera since about 5% of pauciimmune crescentic glomerulonephritis, the pres-ANCA-positive sera are positive only by ELISA • The inclusion of the most recent positive serum in the IIF or ence of a necrotizing glomerular lesion, the demonstra-ELISA studies may be useful in demonstrating a change in tion of ANCA, and the response to immunosuppressive antibody level agents suggested that this was a renal-limited form of Reporting microscopic polyangiitis, even though patients often Nomenclature have constitutional symptoms [13] .
• Reports should use the terms "C-ANCA" for cytoplasmic fluorescence with interlobular accentuation; "C-ANCA (atypical)"
Wegener's granulomatosis, microscopic polyangiitis, for other types of cytoplasmic fluorescence; "P-ANCA" for and Churg-Strauss syndrome are relatively uncommon perinuclear or granulocyte-specific nuclear fluorescence; and conditions but are being diagnosed with increasing fre-"atypical ANCA" for other, less common patterns, such as mixed cytoplasmic and perinuclear fluorescence quency, in part because of the widespread use of ANCA
• Antigen specificities demonstrated by ELISA are described as testing [14] . However, there are currently no satisfactory "PR3-" and "MPO-ANCA" definitions for these diseases. derlying pathology to make a diagnosis [17] . Thus, with the Chapel Hill criteria, a patient has Wegener's granulomatosis when there is necrotizing granulomatous in-ANCA) or MPO has further implications for organ flammation, often of the respiratory tract, but no history involvement, histopathology, and the likelihood of reof asthma, and microscopic polyangiitis when there is a lapse [19, 20] . The Chapel Hill criteria are currently pauciimmune small vessel vasculitis in the absence of being revised to allow for ANCA positivity and antigen granulomatous inflammation and asthma. When the specificity. ACR and Chapel Hill definitions are applied to a cohort of patients with vasculitis, they identify different but overlapping groups (abstract; Bruce et al, Sarcoidosis TESTING FOR ANTINEUTROPHIL Vasc Diffuse Lung Dis 13:270, 1996) [18]. Neither the CYTOPLASMIC ANTIBODIES ACR nor current Chapel Hill criteria takes into account
The most common reason to request a test for ANCA ANCA positivity and target antigen specificity, even is to diagnose or exclude Wegener's granulomatosis or though these are probably important clues to the nature microscopic polyangiitis and to monitor inflammatory of the underlying vasculitis and to subsequent disease activity in these diseases. Recent retrospective and probehavior. For example, the demonstration of ANCA will spective studies have suggested that the results of ANCA indicate an ANCA-associated vasculitis when there is testing have a low sensitivity and specificity for at least only glomerular sclerosis or tubulointerstitial disease, Wegener's granulomatosis [21, 22] , but these analyses and when the histologic appearance cannot be distinhave used the ACR criteria for diagnosis and have demguished from that seen with Henoch Schö nlein purpura, onstrated ANCA by neutrophil IIF alone. cryoglobulinemia, and serum sickness. The subsequent
The "International Consensus Statement on Testing and Reporting of ANCA" (Table 1 ) has been developed demonstration of specificity for proteinase 3 (PR3- disease and rheumatoid arthritis [34, 35] . Granulocytespecific ANA represent a form of P-ANCA, and the International Consensus Statement recommends that to optimize the diagnostic usefulness of ANCA testing they are described as such. The corresponding antigen in patients suspected of having vasculitis, by the adoption specificities are unclear. P-ANCA should be distinof standardized testing and reporting procedures [23] .
guished from the fluorescence seen with anti-dsDNA, Table 2 shows the clinical manifestations that suggest the anti-Ro, anti-lamin, and anti-Golgi antibodies [31] . diagnoses of Wegener's granulomatosis and microscopic "Atypical" ANCA patterns are uncommon and often polyangiitis [24] , and indicate that a test for ANCA comprise a mix of cytoplasmic and perinuclear fluoresshould be performed. In such patients, ANCA positivity cence with multiple antigen specificities [23] . They occur is more likely to indicate a vasculitis than in other hospiwith propylthiouracil and other drugs, even if there is no tal patients. The International Consensus Statement has vasculitis, and are also observed in inflammatory bowel adopted the recommendation of the European standarddisease and rheumatoid arthritis. ization trials that ANCA testing for the diagnosis of In contrast to IIF, ELISAs for PR3-and MPO-ANCA vasculitis requires both IIF examination of normal peproduce an immediate estimate of antibody levels, which ripheral blood neutrophils and ELISAs for PR3-and are usually high at the time of presentation with general-MPO-ANCA [25] . When the IIF assay is positive and ized Wegener's granulomatosis or microscopic polyangione ELISA is performed depending on the IIF pattern, itis and which fall with treatment [36] . The inclusion of this approach produces sensitivities of 73 and 67% for a recent serum in the IIF assay or ELISA may demonWegener's granulomatosis and microscopic polyangiitis, strate a change in antibody level that helps with patient respectively, and a diagnostic specificity of 99% [26] . A management. The sensitivity of ANCA ELISAs is insimilar approach yields positive and negative predictive creased with the "capture" methodology [37] , where the values of 95 and 85% for Wegener's granulomatosis and target antigens are bound to specific monoclonal antimicroscopic polyangiitis, respectively, when there is kidbodies adherent to the plastic ELISA plates, thus overney involvement [27] . These values should be increased coming the effect of protein denaturation from extracby adhering to the minimum requirements of the Intertion or coating procedures. The results with capture national Consensus Statement, where both ELISAs are ELISAs probably correlate better with disease activity performed when the IIF is positive, or the optimal recomand predict relapses more accurately than conventional mendations that all sera should be tested by IIF and in assays. Rapid-screening ELISAs, in which results are both ELISAs. available in less than 60 minutes, and "near patient" Four patterns are demonstrated with IIF ( Fig. 1) .
testing assays that use whole blood are also available. Probably 90% of patients with active generalized WegMost laboratories use commercial kits for both IIF ener's granulomatosis have granular cytoplasmic neutroand ELISAs, and there is good concordance between phil fluorescence with central interlobular accentuation IIF positivity using different types of neutrophil prepara-("C-ANCA") that usually corresponds to PR3 specificity tions, although the fluorescent patterns may differ. How- [28] . About 80% of patients with microscopic polyangiever, sera with C-ANCA produced a concordance rate itis or Churg-Strauss syndrome are ANCA positive, and of 56% with seven different PR3-ANCA kits and sera most with microscopic polyangiitis and about half with with P-ANCA, a rate of only 30% using eight different Churg-Strauss syndrome have perinuclear neutrophil MPO-ANCA assays [38] . Additionally, while PR3-staining, often with nuclear extension ("P-ANCA") and ANCA levels correlated with C-ANCA intensity, there MPO specificity [10] , while the rest have C-ANCA.
was no such correlation between MPO-ANCA and However, most neutrophil fluorescence detected in P-ANCA levels. Further obstacles to the direct comparia routine immunodiagnostic laboratory is not seen in son of ELISA results from different assays are the lack patients with Wegener's granulomatosis or microscopic of international serum standards and the absence of units polyangiitis [29, 30] . "C-ANCA (atypical)" with "flat" neutrophil cytoplasmic fluorescence and without central for PR3-and MPO-ANCA. (Table 3 ). PR3 and MPO are recognized temporaneously with ANCA [40] . An ANA occurs in in most ANCA-positive small vessel vasculitides. PR3 is up to 30% of patients, and these IIF patterns vary and a 29 kD serine protease that breaks down tissue to allow may mask a P-ANCA, which is why the International the passage of neutrophils into an inflammatory focus Consensus Statement recommends that sera containing [44] and is also involved in neutrophil maturation [45] . an ANA should be tested for both PR3-and MPO-MPO helps generate hypochlorite molecules and reac-ANCA. Rheumatoid factor is also common [39] . Antitive oxygen species that are bactericidal [46] . In patients glomerular basement membrane (GBM) antibodies ocwith vasculitis affecting the kidney, ANCA specific for cur together with ANCA in about 5% of patients with human lysosomal membrane glycoprotein (h-lamp2) vasculitis (abstract; Coulthart et al, Clin Exp Immunol have been described together with PR3-or MPO-101:60, 1995). These are usually P-ANCA, but some-ANCA, and may result from cross-reactivity with a renal times C-ANCA [41] . Anti-GBM disease can resemble endothelial surface protein [47] . Their significance, howWegener's granulomatosis and microscopic polyangiitis ever, is unclear. clinically, and some laboratories routinely test all sera at PR3-and MPO-ANCA occur also in a number of presentation for anti-GBM antibodies as well as ANCA other nonvasculitic autoimmune diseases. Their immuno- [42] . Anticardiolipin antibodies [40] and a lupus anticoglobulin class, subclass, and epitope specificity are thought agulant [43] occur in possibly 20% of patients and are to differ from vasculitis-associated ANCA [48] . Addiassociated with an increased risk of thrombosis (abstract; tional ANCA antigens are recognized in inflammatory Mistry et al, Sarcoidosis Vasc Diffuse Lung Dis 13:270, 1996) . bowel disease, autoimmune liver disease, and rheuma- Granulocyte-specific ANA is a form of P-ANCA; many laboratories do not distinguish between P-ANCA and atypical ANCA, and for this reason the frequencies of atypical ANCA are not given. Data are from references given in the text.
toid arthritis and include catalase, ␣ enolase, high mobil-
The characteristic glomerular lesion is a focal segmenity group nonhistone chromosomal proteins (HMG1 and tal necrotizing glomerulonephritis usually with crescents, HMG2), actin, BPI, cathepsin G, elastase, lactoferrin, and sometimes with disruption of Bowman's capsule and and lysozyme (abstract; Flesch et al, Am J Kidney Dis periglomerular tubulointerstitial inflammation from the 18:201, 1991) [49] [50] [51] [52] [53] [54] [55] [56] . ANCA specific for these antigens spillage of inflammatory mediators. There is less endoindividually result in P-ANCA, except for BPI-ANCA, capillary hypercellularity and more disruption of Bowwhich sometimes produces C-ANCA (atypical) [57] . Howman's capsule than occurs in immune complex crescentic ever, ANCA in inflammatory bowel disease, autoimglomerulonephritis. Uninvolved glomerular segments mune liver disease, and rheumatoid arthritis often have are often almost normal, and tubulointerstitial disease multiple specificities, resulting in an "atypical" fluoressometimes occurs without any obvious glomerulonecence pattern. Interestingly h-lamp2, catalase, ␣ enolase, phritis. HMG1 and HMG2, and actin are all found in cells other
Immunofluorescence microscopy of the glomeruli and than neutrophils, and while currently described as other vessels characteristically demonstrates few immu-"ANCA," may be more accurately named in the future.
noglobulin deposits [61] , which distinguishes the lesions Further antigens include defensins [58] that have been from immune complex glomerulonephritis where there recognized in some parasitic infections, and azurocidin are granular deposits, and from the linear staining of anti- [59] , which is of uncertain significance.
GBM disease. However, there is some overlap between the amount of immunoglobulin seen in pauciimmune PATHOLOGY and immune-complex-mediated glomerulonephritis, and thus, the frequency of ANCA positivity in immune comThe characteristic histologic lesion of the ANCA-assoplex glomerulonephritis depends on the definition of ciated small vessel vasculitides is focal fibrinoid necrosis "pauciimmune" [62] . of the capillaries and venules. However, involvement of Lung disease is common in the ANCA-associated small arterioles and small arteries is common [17] , and "overvessel vasculitides (Tables 4 and 5 ). Capillaritis is the lap" with medium or large vessel disease occurs in nearly most frequently seen vascular lesion [63] , and airways half of all patients with microscopic polyangiitis [60] . By and interstitial disease are more common when C-ANCA convention, when medium or large vessel involvement is present, but otherwise, there is no histologic lesion occurs, the disease is still called microscopic polyangiitis, Wegener's granulomatosis, or Churg-Strauss syndrome.
that differentiates between C-ANCA and P-ANCA- responded to treatment [71] . Central nervous system associated disease. The corresponding radiographic abdisease is recognized increasingly with the use of magnormalities are nodules, bilateral fluffy opacities, and netic resonance imaging. Skin lesions usually parallel the less often lobar consolidation and honeycomb lung [64] .
activity in other organs. Open lung biopsy of the pulmonary parenchyma has the Wegener's granulomatosis is rare in the very young. highest diagnostic yield, with characteristic abnormaliHowever, in children over the age of 7 and in adolescents, ties in more than 90% of specimens [65] . Transbronchial the features resemble adult disease, except that subglotbiopsies of tracheobronchial lesions, and even renal bioptic stenosis and nasal deformity are more common, and sies, are usually more helpful than transbronchial biopsies fewer cyclophosphamide-related malignancies ensue of alveolar tissue [66] . Within a week of starting treat- [72] . As in adults, early recognition and treatment are ment, the histologic appearance of these lung abnormaliimportant to improve the renal outcome [73] . Pregnancy ties begins to improve, but interstitial fibrosis commonly is uncommon in the age group affected by Wegener's results [67] .
granulomatosis, but may trigger the onset of disease and relapse [74] . Cyclophosphamide is teratogenic in the first CLINICAL SYNDROMES OF ANTINEUTROPHIL trimester of pregnancy.
CYTOPLASMIC ANTIBODY-ASSOCIATED
About half of all patients with Wegener's granuloma-VASCULITIDES tosis are aged over 60 years. In the older population, The pattern of organ involvement is similar in Wegenpresenting features are similar to those in younger indier's granulomatosis and microscopic polyangiitis (Table  viduals , but the outcome is often worse, with uncon-4). Together these diseases account for 60% of all patrolled pulmonary vasculitis and treatment-associated intients with rapidly progressive glomerulonephritis [68] fections being common causes of death [75, 76] . ANCA and are the most common cause of the pulmonary-renal do not occur incidentally in the normal older population, syndrome in adults [69] . These observations contrast unlike ANA and rheumatoid factor [77] . with Churg-Strauss syndrome, in which renal failure and Genetic risk factors for the development of pulmonary hemorrhage are less common. thermore, patients with the Z phenotype have more organs involved, more progressive disease, and a higher "Limited" Wegener's granulomatosis is recognized with mortality rate [79, 80] . ␣ 1 AT is the major inhibitor of increasing frequency, but probably 80% of patients go PR3 (abstract; van der Wiel et al, Am J Kidney Dis on to develop renal involvement [1] , indicating that "lim-18:206, 1991) and competes with ANCA for binding to ited" and "generalized" disease are part of a continuum the PR3 catalytic site [81] . Thus, abnormal ␣ 1 AT phenoand that long-term follow-up is essential.
types result in high circulating concentrations of un-"Generalized" Wegener's granulomatosis bound uninhibited PR3 that can lead to autoantibody production in an immunologically active environment. Patients with "generalized" Wegener's granulomatosis have disease affecting the kidneys as well as other organs
In addition, ␣ 1 AT inhibits other neutrophil proteolytic enzymes as well as PR3, and defective or deficient ␣ 1 AT ( 13:269, 1996) . the diagnosis of Churg-Strauss syndrome can be made At least half of all patients with microscopic polyangiwhen there is asthma, a peak peripheral blood eosinoitis have arterial involvement and an "overlap syndrome" philia Ͼ 1.5 ϫ 10 9 /L, and a systemic vasculitis affecting with features of both microscopic polyangiitis and polytwo or more extrapulmonary organs [85] . These features arteritis nodosa [60] . Thus, in addition to glomeruloneoccur sequentially over a period of years, and the clinical phritis, these patients may have bowel or renal ischemia diagnosis should be confirmed histologically wherever and a peripheral neuropathy from medium vessel involvement. Arterial disease is indicated by an arcuate possible. Myocardial vasculitis is not uncommon and is or interlobular arteritis in the renal biopsy and the dema major cause of morbidity. Renal involvement is less onstration of aneurysms at surgery or angiographically.
common than in the other small vessel vasculitides. This "overlap syndrome" differs from polyarteritis nodosa in that ANCA are present [60], the disease does TREATMENT not respond to corticosteroids alone, and relapses occur.
Treatment of generalized Wegener's granulomatosis Differences between proteinase 3-and and microscopic polyangiitis myeloperoxidase-antineutrophil cytoplasmic
Histologic confirmation of the diagnosis of Wegener's antibody-associated vasculitides granulomatosis or microscopic polyangiitis is almost alPatients with PR3-ANCA-associated disease have ways required before treatment is instituted because of eye, ear, nose, and upper respiratory tract involvement the associated risks. Similar regimens are used for both more often, as well as tissue granulomata and an inWegener's granulomatosis and microscopic polyangiitis, creased relapse rate [20, 84] . Patients with MPO-ANCAalthough there have been no prospective controlled trials associated vasculitis are often older, usually have glomerin microscopic polyangiitis. The responses to treatment ulonephritis, and have other autoantibodies too [19, 84] .
can be measured using "disease activity" [Birmingham While renal lesions are more active and kidney function vasculitis activity score (BVAS)] [86] , "disease remisdeteriorates more rapidly in patients with PR3-ANCAsion," "treatment resistance," and "relapse," as defined associated vasculitis [20] , overall, the outcome for pain Table 6 [87]. Treatment-associated morbidity often tients and for their renal function appears to be the same exceeds the complications from the disease or relapse for both PR3-ANCA-and MPO-ANCA-associated dis- [88] so that minor clinical features should probably be ease [19] . tolerated rather than treated aggressively, and less toxic Antineutrophil cytoplasmic antibody-negative regimens are being actively sought ( Renal disease with serum creatinine Ͼ500 mmol/L creatinine concentration accompanied by an active urinary sediment;
• Oral corticosteroids and cyclophosphamide and IV methylpredni-(B) a renal biopsy demonstrating active necrosis or crescent formasolone tion; (C) hemoptysis, pulmonary hemorrhage or new and expanding
• Oral corticosteroids and cyclophosphamide and plasma exchange nodules without evidence for infection; (D) active vasculitis of the
Refractory disease in WG, MPA (SOLUTION) respiratory or gastrointestinal tract as demonstrated by endoscopy
Frequently relapsing or progressive disease, life-threatening, stanwith biopsy; (E) iritis or uveitis; (F) new neuropathy; or (G) necrotizdard treatment of no use ing vasculitis identified by biopsy in any tissue.
• ATG daily for 10 subsequent days is usually short lived [95] [96] [97] [98] . Both pulse prednisolone GFR Ͻ50 mL/min for WG only, and in remission after 18 months from start of clinical trial and plasma exchange appear, however, to be effective angiitis. Modified from [90] 
with permission from Clinical and Experimental
Most patients respond immediately to treatment.
Immunology.
Within a week, symptoms and signs improve, although deafness and neuropathy respond more slowly and sometimes incompletely. Urinary red blood cell counts and Relapses are more common with the shorter course of C-reactive protein (CRP) plateau in the first week and cyclophosphamide, but the overall loss of function and then fall, but take up to two months to become normal. treatment-related morbidity may be acceptable. Serum creatinine usually plateaus in the first week and
In patients with Wegener's granulomatosis, the addithen falls, and the maximal improvement in creatinine tion of one double-strength tablet of trimethoprim/sulfaclearance occurs within two months. Lung hemorrhage methoxazole twice daily in addition to immunosuppresoften clears radiographically within a week, but nodules sive medication reduces the frequency of upper restake a month or more. Although ANCA are reported piratory tract relapses [100], possibly by eradicating local to disappear within three months [99], in our experience, S. aureus. However, it is poorly tolerated, and mupiroit is often longer. mycin may be preferable, although its efficacy in preMaintaining remission venting relapses is still unproved. Monthly pulse cyclophosphamide results in a lower Prednisolone is usually tapered to 20 mg at three cumulative dose and lower toxicity compared with daily months and is then reduced further. Cyclophosphamide administration, but there are fewer disease remissions, is continued for at least a year after remission with the a lower rate of recovery from dialysis, and more relapses NIH regimen [91] , but is replaced with azathioprine after three to six months with the Hammersmith protocol [96] . Anti-T-cell treatment has a role in occasional patients Wegener's granulomatosis, but three of the nonresponders (16%) developed severe generalized disease. Thus, [108] [109] [110] . A single course of anti-T-cell therapy in which immunosuppressives were continued resulted in an imtrimethoprim/sulfamethoxazole alone cannot be used to induce remission even in patients with limited disease. provement in four of five patients with a high cumulative dose of cyclophosphamide or refractory disease [108] , Future treatments and partial or complete remission was maintained for the 5 to 12 months of review. Side effects were transient, Novel treatments have been identified from our increased understanding of the pathogenetic mechanisms but repeated dosing was limited by an antiglobulin response. In a subsequent study, all six patients with unreunderlying the ANCA-associated vasculitides [118] . These variously reduce circulating ANCA levels, deplete neusponsive disease who were treated with anti-CD52 ϩ/Ϫ anti-CD4 antibodies [110] and in whom immunosupprestrophils, inhibit the cytokines tumor necrosis factor-␣ and interleukin-1 (such as thalidomide, oxypentifylline, sives were withdrawn improved, and while four subsequently relapsed after 1.5 to 18 months, these responded and soluble tumor necrosis factor receptors), inhibit the adhesion molecules that mediate neutrophil-endothelium to further treatment. Treatment was, however, associated with a prolonged reduction in circulating CD4 interaction (abstract; Elliott et al, Clin Exp Immunol 112:57, 1998), or interfere with T-cell responses (cycloscounts, and some patients relapsed when counts became normal but responded to further doses. There was no porine A [119, 120], FK506, tacrolimus, mycophenolate mofetil [121] , serolimus, and deoxyspergualin). Some of increased rate of opportunistic infections or lymphoma. Treatment with anti-CD52 antibodies, nevertheless, these agents have already proved effective in individual case reports or small prospective studies. Cyclosporine should be reserved for patients with resistant and lifethreatening disease.
( efficacy has been unproved. Data support the use of weekly methotrexate in the Treatment of Churg-Strauss syndrome induction phase and to maintain remission in patients with limited Wegener's granulomatosis. In one study, Churg-Strauss syndrome is rare, and its treatment has usually been studied in series that include patients with more than 40 patients were treated with corticosteroids and 20 to 25 mg methotrexate weekly, and were followed polyarteritis nodosa. In such reports, glucocorticoids alone and glucocorticoids together with cyclophosphadom biopsies every one to two years. The risk of bladder cancer is 11 times greater than for the rest of the populamide have been efficacious [122] . However, any patient with organ-or life-threatening disease should probably tion after just one year of cyclophosphamide treatment in microscopic polyangiitis [125] . receive both glucocorticoids and a cytotoxic agent as the initial treatment [122] . In contrast to the other small Relapses vessel vasculitides, pulse cyclophosphamide together with steroids may be effective in the Churg-Strauss syn-
The frequency of relapses depends on how they are defined, different treatment regimens, and the duration drome. High-dose interferon ␣ also maintains remission in patients who have responded incompletely to cycloof follow-up. With the Hammersmith regimen, 42% of 45 patients with Wegener's granulomatosis and 27% of phosphamide (abstract; Tatsis et al, Clin Exp Immunol 112:56, 1998).
15 with microscopic polyangiitis relapsed within a year of presentation [36] . Relapses usually occur when the immunosuppressive dose is reduced or ceased, especially OUTCOME within the first two years of treatment. Relapses are more Morbidity in patients with Wegener's granulomatosis common in patients with C-ANCA and PR3 specificity, or microscopic polyangiitis results from the effects of in patients with Wegener's granulomatosis with persisboth the underlying disease and its treatment. It can be tent nasal S. aureus [128] , and when induction treatment quantitated using the vasculitis damage index (VDI) and does not include cyclophosphamide [91] . Relapses are the short form 36 (SF36) [123] , which measures quality equally likely in patients with limited and generalized of life, but these tools are more useful in evaluating disease [36] . treatment protocols than in assessing individual patients.
Antineutrophil cytoplasmic antibodies recur or persist Overall, the single most important factor in determining in at least half the patients who relapse, and there is the outcome for a patient is the presence of renal disease, usually a fourfold or greater increase in IIF titer [99] , and the strongest predictor of renal outcome is the serum and at least a doubling of IgG3 subclass ANCA [129] . creatinine at presentation [124] . The predictive value of However, relapses (and disease progression) can occur a renal biopsy at presentation is limited, but high ANCA in the absence of ANCA positivity, and only about half of levels or persistent circulating ANCA may be associated all patients in whom ANCA recur or who are persistently with worse disease [125, 126] . Mortality is increased in positive will relapse. patients who present late, who have pulmonary hemorThe average time from ANCA increase to relapse is rhage or C-ANCA-associated disease, or who are reported to be seven weeks [36] . Most relapses involve treated with corticosteroids alone [90, 124] .
the same organs that were affected initially, but renal Disease-related morbidity occurs in possibly 90% of involvement can occur for the first time at relapse. Lung patients and arises from delays in instituting treatment, relapses usually occur if the lung was involved initially, progression of subclinical disease, and the tendency to but often at new sites. Lung relapses and infections may relapse. Complications include sinus dysfunction (in be difficult to distinguish clinically, but relapses are rare 47%), renal impairment (42%), hearing loss (35%), and in the early phase of treatment when high doses of treatmoderate to severe respiratory disease (17%) [91] . ment are used. If confusion persists, a histologic diagnosis The greatest risks of treatment of Wegener's granuloshould be obtained as quickly as possible. Occasionally, matosis with the NIH cyclophosphamide regimen are relapses affect patients on dialysis or after transplantainfections and bladder cancer. In one series, infections tion [36] . required hospitalization in nearly half the patients, and
Minor relapses are treated with an increase in dose of transitional cell bladder cancer was 30 times more comcorticosteroids and immunosuppressives. Major relapses mon than in the general population [127] . Half the paare treated with reinstitution of the induction regimen, tients had nonglomerular hematuria after a median of after which doses can be tapered more quickly to just 8.5 years, 70% of these had cyclophosphamide-induced above the levels at which relapse occurred. Relapses cystitis at cystoscopy, and 16% were estimated to deusually respond quickly to treatment and may be prevelop bladder cancer at 15 years. This group recomvented by longer initial immunosuppressive courses, mended that all patients treated with cyclophosphamide monthly ANCA monitoring [36] , and long-term trimethshould have urine microscopy every three to six months oprim/sulfamethoxazole in patients with Wegener's for life. If nonglomerular hematuria was present, patients granulomatosis [100]. In one study, none of nine patients should have a cystoscopy, and if hemorrhagic cystitis who were treated on the basis of an increase in ANCA was demonstrated, cyclophosphamide should be ceased, subsequently relapsed, while 9 of 11 (82%) who were except in life-threatening circumstances. Individuals with not treated did [130] . However, most clinicians would cyclophosphamide-associated cystitis should have urinot reinstitute or increase immunosuppressive treatment on the basis of an increased ANCA level alone, but nary cytology every six months and cystoscopy and ran- Drug-induced systemic vasculitis [132] . ANCA levels often fall progressively after transplantation [133] . Relapses following transplantation are
The most common drugs that induce ANCA and an uncommon [134] and occur less often than in dialyzed associated vasculitis are propylthiouracil and related patients [132] . The risk of relapse is minimized if cyclodrugs, and hydralazine [12, 145] . ANCA can be demonphosphamide has been used in the induction regimen by strated at some time in about 20% of all patients treated waiting six months after presentation or the most recent with propylthiouracil (abstract; Cohen Tervaert et al, relapse, and preferably until ANCA are undetectable, Sarcoidosis Vasc Diffuse Lung Dis 13:280, 1996), and and by including azathioprine and possibly cyclosporine antigen specificities are usually multiple and include in the antirejection regimen [134] [135] [136] [34, 149] . In patients fibrosis [169] , and antibody levels are higher in patients with ulcerative colitis, ANCA are independent of disease with an associated secondary vasculitis, or pseudomonas extent, persist after colectomy, and do not predict the colonization. C-ANCA (atypical) occur in suppurative development of pouchitis after surgery [150] . Furtherlung disease [170] . more, antibody status changes with time in individual patients [151] . In Crohn's disease, studies that suggested Infections P-ANCA occur more often when the left side of the In addition to the associations with infections decolon was affected [152] , thus resembling the distribution scribed earlier in this article, ANCA have been described in ulcerative colitis, have not been reproduced [153] .
in isolated cases of subacute bacterial endocarditis [171], IgA ANCA occur in both ulcerative colitis and Crohn's and in malaria [172] , invasive amoebiasis [173], blastodisease, but their significance is uncertain. Interestingly, mycosis [174] , leptospirosis [175] , and onchocerciasis ANCA have been described in patients with infective [58] . The demonstration of ANCA in HIV [176] probably enteritis [149] .
Antineutrophil cytoplasmic antibodies occur in more results from nonspecific serum stickiness after heat treatthan 70% of patients with primary sclerosing cholangitis ment to denature the virus, and the presence of ANCA or chronic active hepatitis and in about 30% of patients in some of the other infections may be related in part with primary biliary cirrhosis [154] . Again, these are to the associated hypergammaglobulinemia [30] . P-ANCA or atypical ANCA, and the specificities include actin [53] , HMG1/2 (abstract; Ozaki et al, Clin Exp Immunol 112:120, 1998), and the antigens recognized in CONCLUSIONS inflammatory bowel disease. In these diseases, ANCA
The demonstration of ANCA has proved enormously may correlate with the degree of cirrhosis. ANCA are helpful in the diagnosis of the small vessel vasculitides. uncommon in nonautoimmune liver disease [154] .
While it is still not clear that ANCA actually contribute to the pathogenesis of these diseases, there is increasing Arthritis evidence, especially from models of vascular damage, Low levels of P-ANCA (including granulocyte-specific that this is so. However, the clinical and pathogenetic nuclear fluorescence) or atypical ANCA have been demsignificance of ANCA in the nonvasculitic diseases reonstrated in 20 to 70% patients with rheumatoid arthritis mains poorly understood. ANCA probably do not correlate with particular pat-CRP, C-reactive protein; GBM, glomerular basement membrane; IIF, indirect immunofluorescence; IL-1, interleukin-1; IVIg, intravenous terns of organ involvement [164] , the presence of vasculiimmunoglobulin; MPO, myeloperoxidase; P-ANCA, perinuclear tis [165], or disease activity [166] . Individual studies have ANCA; PR3, proteinase 3; RBC, red blood cell; SF36, short form 36 suggested that certain antigen specificities may be cliniindex to measure quality of life; SLE, systemic lupus erythematosus; TNF-␣, tumor necrosis factor-␣; VDI, vasculitis damage index. cally significant, but these are inconsistent [167, 168] .
